BayBio Notes
1 2 3 4 5 10 20 100 > >>
- Upcoming Life Science Events plus Free Webinar - Feb 3, 2012
I’m currently very involved in doing research in preparation for my upcoming Life Science Product Marketing class starting Feb. 15th and my role as moderator for the upcoming free...
Read More... - Talon leukemia drug gets date with FDA advisory panel - Feb 3, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/DeitcherSteven.jpeg?v=3'>Talon Therapeutics Inc. must hurdle a Food and Drug Administration advisory panel March 21...
Read More... - Early data show kidney cancer response to Exelixis' 'cabo' - Feb 3, 2012
Exelixis Inc.’s experimental cancer drug cabozantinib showed promise in patients with a form of metastatic kidney cancer, according to a preliminary report from an early-stage trial. The South...
Read More... - Threshold lands $25M upfront, possible $525M more, in cancer drug deal - Feb 3, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/print-edition/SelickBarry3191_pv11*100.jpg?v=1'>Threshold Pharmaceuticals Inc. landed a $25 million upfront payment — with the...
Read More... - Combined Approach to Global Health Can Save Lives at Lower Cost - Feb 3, 2012
A new analysis published this week demonstrates that confronting several diseases at once is a viable way to make the most of limited donor dollars and national health care budgets, and save more...
Read More... - Gilead stock rises on potential hepatitis C cure - Feb 3, 2012
<img src='http://assets.bizjournals.com/sanjose/news/Gilead*100.jpg?v=1'>Gilead Sciences Inc.’s pricey acquisition of Pharmasset Inc. and its lead hepatitis C drug already may be...
Read More... - Combined Approach to Global Health Can Save Lives at Lower Cost - Feb 3, 2012
A new analysis published this week demonstrates that confronting several diseases at once is a viable way to make the most of limited donor dollars and national health care budgets, and save more...
Read More... - Combined Approach to Global Health Can Save Lives at Lower Cost - Feb 3, 2012
A new analysis published this week demonstrates that confronting several diseases at once is a viable way to make the most of limited donor dollars and national health care budgets, and save more...
Read More... - DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs - Feb 3, 2012
FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation today announced the availability of an industry leading platform for studying Bromodomains, an emerging class of epigenetic targets. The new...
Read More... - Natera’s Non-Invasive Prenatal Diagnostic to Detect Down Syndrome, Trisomy 13, Trisomy 18 and Certain Sex Chromosome Abnormalities in the First Trimester of Pregnancy - Feb 3, 2012
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Natera, formerly known as Gene Security Network, today announced that details about the breadth of the company’s non-invasive prenatal diagnostic test will...
Read More... - UCSF Spinal Surgery Saves Former Gymnast's Life - Feb 3, 2012
In a triumph of the human spirit and life-saving health care, Angelica Galang, 23, is now attending law school after UCSF neurosurgeon Philip Weinstein removed a five-inch tumor in one of the most...
Read More... - Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With Advanced Renal Cell Carcinoma - Feb 3, 2012
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell...
Read More... - Breast Cancer Action donations surge after Komen-Planned Parenthood fiasco - Feb 2, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/BreastCancerAction.jpg?v=1'>Believe it or not, there is a beneficiary of the controversial decision by Susan G....
Read More... - SGI Takes Global Genomics Marketing Campaign to a New Level - Feb 2, 2012
FREMONT, Calif.--(BUSINESS WIRE)--SGI (NASDAQ: SGI), the trusted leader in technical computing, today announced that it has initiated a global, integrated marketing campaign targeting genomics...
Read More... - Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results - Feb 2, 2012
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today its results of operations for the fourth quarter and full year 2011. Total revenues for the fourth quarter...
Read More... - Affymax Promotes Cynthia Smith to Vice President, Market Access and Commercial Development - Feb 2, 2012
PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced the promotion of Cynthia Smith to vice president, market access and commercial development. Ms. Smith, who has 15...
Read More... - FDA expands age range for Dynavax vaccine to 18-70 years - Feb 2, 2012
Dynavax Technologies Corp. met the Food and Drug Administration and the agency agreed to expand the age range for use of the company’s Heplisav vaccine for hepatitis B. Berkeley-based Dynavax...
Read More... - StemCells gets FDA nod for eye trial using neural stem cells - Feb 2, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/print-edition/McglynnMartin8729_sb11*100.jpg?v=1'>An early-stage clinical trial using purified neural stem cells to treat dry...
Read More... - Auxogyn raises $20 million - Feb 2, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/L%20Goldenstein347*100.jpg?v=1'>Auxogyn Inc., a Menlo Park startup aimed at helping in vitro fertilization clinics...
Read More... - What Patients Talk About When They Talk About Doctors - Feb 2, 2012
An analysis of hundreds of reviews posted to physician-rating sites on the Internet revealed that patients generally give their doctors favorable reviews in this forum. If they complain, it is...
Read More...
